AND — Andlauer Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$1.70bn
- CA$1.82bn
- CA$647.95m
- 91
- 39
- 77
- 78
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 30.3 | 37.7 | 90 | 76.3 | 66.1 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 1.5 | 3.13 | -38.5 | 1.52 | 1.5 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 3.09 | -11.6 | -6.25 | -3.08 | -26.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 61 | 51 | 84.1 | 137 | 104 |
Capital Expenditures | -6.17 | -5.44 | -9.67 | -28 | -25.6 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | -14.9 | -174 | -17.6 | 1.74 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -6.17 | -20.4 | -183 | -45.6 | -23.8 |
Financing Cash Flow Items | 26.1 | 13.4 | -6.2 | -0.67 | -0.188 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -89.8 | -19.2 | 93.9 | -51.6 | -86.2 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -34.9 | 11.4 | -5.16 | 40.9 | -6.12 |